Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, November 25, 2009, 7:57am EST - Canadian Markets open in 1 hour and 33 minutes.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
Qiagen NV (QGEN)
On Nov 24:
21.36 USD
0.00 (0.00%)
MORE ON QGEN
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
Qiagen N.V.
(NasdaqNM:QGEN) Delayed quote data
Pre-Market:
21.86
0.50 (2.34%)
as of 7:33am EST on 11/25/09
Last Trade:
21.36 USD
Trade Time:
Nov 24
Change:
0.00 (0.00%)
Prev Close:
21.36
Open:
N/A
Bid:
21.88
x 1000
Ask:
21.90
x 100
1y Target Est:
23.41
Day's Range:
N/A - N/A
52wk Range:
14.32 - 23.58
Volume:
22,000
Avg Vol
(3m)
:
1,163,000
Market Cap:
4.94B
P/E
(ttm)
:
63.95
EPS
(ttm)
:
0.33
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Free Annual Reports
Add QGEN to Portfolio
Download Data
HEADLINES
Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
Wall Street Transcript
(Fri, Nov 20)
Q3 2009 Qiagen N.V. Earnings Release - Time Not Supplied
CCBN
(Tue, Nov 10)
QIAGEN to Acquire SABiosciences
Marketwire
(Mon, Nov 9)
UPDATE - Qiagen beats estimates, tweaks outlook on test sales
at Reuters
(Mon, Nov 9)
Healthcare Bill Will Be Law By New Year Says Morningstar Strategist
Wall Street Transcript
(Mon, Nov 9)
[$$] Stocks Jump Despite Rising Unemployment
at Barrons.com
(Sat, Nov 7)
QIAGEN and British Veterinary Laboratories Agency Expand Partnership in Veterinary Testing
Business Wire
(Thu, Nov 5)
Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Quarter 2009 Financial Results Call Set for November 10
PRNewswire
(Tue, Nov 3)
Neurogenic Orthostatic Hypotension Treatment Should Pass Phase III Trials: Catalyst For Biotech Stock Says Wedbush Morgan Analyst
Wall Street Transcript
(Tue, Oct 20)
Coverage initiated on Qiagen by Barclays Capital
Briefing.com
(Wed, Oct 7)
More Headlines for QGEN...
ANALYST
EPS Est (next year)
(Dec-07)
:
N/A
EPS Est (in 2 years)
(Dec-08)
:
N/A
Avg Rec (current)*:
2.2
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
QIAGEN N.V., through its subsidiaries, engages in the development, manufacture, and marketing of products for the handling, separation, purification, and subsequent use of nucleic acids and proteins.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices